SciELO - Scientific Electronic Library Online

 
vol.8 número1Prevalencia de la deficiencia de glucosa - 6 - fosfato deshidrogenasa en donadores voluntarios de sangre que acuden a los hospitales nacionales Cayetano Heredia y Arzobispo Loayza: Lima - Perú índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista Medica Herediana

versão impressa ISSN 1018-130Xversão On-line ISSN 1729-214X

Resumo

VELASCO, José et al. Two therapeutics plans for management asthmatic crisis in children. Rev Med Hered [online]. 1997, vol.8, n.1, pp.5-10. ISSN 1018-130X.

Objective: To compare the clinical and side effects of two therapeutics schedules in the treatment of asthmatic crisis: The association of fenoterol 100 ug Metered Dose Inhaler (MDI) with spacer device plus dexamethasone IV and salbutamol 10 ug MDI with spacer device plus hydrocortisone IV. Material and Methods: In a ramdomized, prospective, longitudinal, open and multicentric trial we included 60 children with mild-moderate asthmatic crisis (30 for each group). Both groups were comparables at initial evaluation. Results: There were no significative difference in respiratory rate, clinical score, peak expiratory flow rate (PEF), and tremor (p>0.05). We found more heart rate at first 30 and 60 minutes in Fenoterol - Dexamethasone group (p£ 0.05). There were no significative differences in the amount of discharges from hospital at the end of the study (4 hours). Conclusions: We conclude that the association Fenoterol-dexamethasone and Salbutamol-Hydrocortisone are equally effective in the management of mild to moderate asthmatic crisis in children. (Rev Med Hered 1997; 8: 5-10).

Palavras-chave : Fenoterol; salbutamol; dexamethasone; hydrocortisone; asthma; children.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons